BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9636378)

  • 1. Combined blockade of CD28/B7 and CD40/CD40L costimulatory pathways prevents the onset of chronic rejection.
    Subbotin V; Sun H; Chen C; Aitouche A; Valdivia L; Fung JJ; Starzl TE; Rao AS
    Transplant Proc; 1998 Jun; 30(4):941-2. PubMed ID: 9636378
    [No Abstract]   [Full Text] [Related]  

  • 2. Blockade of the CD28/B7 and CD40/CD40L costimulatory pathways does not ameliorate chronic rejection in a mouse aortic allograft model of direct antigen presentation.
    Tang JL; Woodward JE; Subbotin V; Logar AJ; Sun H; Valdivia LA; Schaefer AT; Zottola LB; Peach R; Fung JJ; Rao AS
    Transplant Proc; 2001; 33(1-2):382. PubMed ID: 11266872
    [No Abstract]   [Full Text] [Related]  

  • 3. Aggressive skin allograft rejection in CD28-/- mice independent of the CD40/CD40L costimulatory pathway.
    Ha J; Bingaman AW; Durham MM; Pearson TC; Larsen CP
    Transpl Immunol; 2001 Oct; 9(1):13-7. PubMed ID: 11680567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD40 signaling replaces CD4+ lymphocytes and its blocking prevents chronic rejection of heart transplants.
    Fischbein MP; Ardehali A; Yun J; Schoenberger S; Laks H; Irie Y; Dempsey P; Cheng G; Fishbein MC; Bonavida B
    J Immunol; 2000 Dec; 165(12):7316-22. PubMed ID: 11120867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways.
    Hayakawa Y; Takeda K; Yagita H; Van Kaer L; Saiki I; Okumura K
    J Immunol; 2001 May; 166(10):6012-8. PubMed ID: 11342617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutting edge: the relative distribution of T cells responding to chemically dominant or minor epitopes of lysozyme is not affected by CD40-CD40 ligand and B7-CD28-CTLA-4 costimulatory pathways.
    DiPaolo RJ; Unanue ER
    J Immunol; 2002 Sep; 169(6):2832-6. PubMed ID: 12218093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cellular immune responses to encapsulated porcine islet xenografts by simultaneous blockade of two different costimulatory pathways.
    Safley SA; Kapp LM; Tucker-Burden C; Hering B; Kapp JA; Weber CJ
    Transplantation; 2005 Feb; 79(4):409-18. PubMed ID: 15729166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of chronic rejection in mouse aortic allografts by combined treatment with CTLA4-Ig and anti-CD40 ligand monoclonal antibody.
    Sun H; Subbotin V; Chen C; Aitouche A; Valdivia LA; Sayegh MH; Linsley PS; Fung JJ; Starzl TE; Rao AS
    Transplantation; 1997 Dec; 64(12):1838-43. PubMed ID: 9422428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the CD40 and CD28 pathways on alloimmune responses by CD4+ T cells in vivo.
    Bingaman AW; Ha J; Durham MM; Waitze SY; Tucker-Burden C; Cowan SR; Pearson TC; Larsen CP
    Transplantation; 2001 Oct; 72(7):1286-92. PubMed ID: 11602857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid induction of a novel costimulatory activity on B cells by CD40 ligand.
    Wu Y; Xu J; Shinde S; Grewal I; Henderson T; Flavell RA; Liu Y
    Curr Biol; 1995 Nov; 5(11):1303-11. PubMed ID: 8574588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of Fas/FasL apoptotic pathway in the development of chronic rejection.
    Subbotin V; Sun H; Aitouche A; Salam A; Valdivia LA; Fung JJ; Starzl TE; Rao AS
    Transplant Proc; 1999; 31(1-2):1397-8. PubMed ID: 10083618
    [No Abstract]   [Full Text] [Related]  

  • 13. Modulation of costimulation by CD28 and CD154 alters the kinetics and cellular characteristics of corneal allograft rejection.
    Ardjomand N; McAlister JC; Rogers NJ; Tan PH; George AJ; Larkin DF
    Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):3899-905. PubMed ID: 12939307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Without CD4 help, CD8 rejection of pig xenografts requires CD28 costimulation but not perforin killing.
    Zhan Y; Brady JL; Sutherland RM; Lew AM
    J Immunol; 2001 Dec; 167(11):6279-85. PubMed ID: 11714791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the B7 costimulatory pathway in allograft rejection.
    Pearson TC; Alexander DZ; Corbascio M; Hendrix R; Ritchie SC; Linsley PS; Faherty D; Larsen CP
    Transplantation; 1997 May; 63(10):1463-9. PubMed ID: 9175811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential graft-versus-leukaemia effect by CD28 and CD40 co-stimulatory blockade after graft-versus-host disease prophylaxis.
    Ohata J; Sakurai J; Saito K; Tani K; Asano S; Azuma M
    Clin Exp Immunol; 2002 Jul; 129(1):61-8. PubMed ID: 12100023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic characterization of strain differences in the ability to mediate CD40/CD28-independent rejection of skin allografts.
    Williams MA; Trambley J; Ha J; Adams AB; Durham MM; Rees P; Cowan SR; Pearson TC; Larsen CP
    J Immunol; 2000 Dec; 165(12):6849-57. PubMed ID: 11120808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged allograft survival following ex vivo blockade of costimulatory signals B7-1/2 and CD40.
    Steurer W; Oellinger R; Perwanger F; Brandacher G; Obrist P; Klima G; Margreiter R
    Transplant Proc; 2001; 33(1-2):274-5. PubMed ID: 11266816
    [No Abstract]   [Full Text] [Related]  

  • 19. The CD154/CD40 interaction required for retrovirus-induced murine immunodeficiency syndrome is not mediated by upregulation of the CD80/CD86 costimulatory molecules.
    Green KA; Cook WJ; Sharpe AH; Green WR
    J Virol; 2002 Dec; 76(24):13106-10. PubMed ID: 12438641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different costimulation signals used by CD4(+) and CD8(+) cells that independently initiate rejection of allogenic hepatocytes in mice.
    Gao D; Li J; Orosz CG; Bumgardner GL
    Hepatology; 2000 Nov; 32(5):1018-28. PubMed ID: 11050052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.